Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Initiation of Translation02:33

Initiation of Translation

30.7K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
30.7K
Types of RNA01:23

Types of RNA

63.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.2K
Leaky Scanning02:28

Leaky Scanning

5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Improving Translational Accuracy02:07

Improving Translational Accuracy

8.8K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Options for Metallo-Beta-Lactamase-Producing <i>Enterobacterales</i> in the Era of Increasing Resistance.

International journal of molecular sciences·2026
Same author

Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time-Dependent Expression of Messenger RNA and Self-Amplifying RNA.

ChemMedChem·2026
Same author

Novel Small Molecule GLP-1R Agonists Based on 1<i>H</i>-Benzo[<i>d</i>]imidazole-5-Carboxylic Acid Scaffold.

Molecules (Basel, Switzerland)·2026
Same author

A comprehensive analysis of the use of nucleoside analogues in RNA therapeutics.

Journal of translational medicine·2026
Same author

Functional In Vitro Assessment of rAAV-Delivered Retinol Dehydrogenase 12 (RDH12) Activity.

International journal of molecular sciences·2026
Same author

RNA-Based Therapeutic Strategies in Multiple Myeloma: From Molecular Targets to Delivery and Clinical Translation.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jun 4, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K

Current Progress in the Development of mRNA Vaccines Against Bacterial Infections.

Alina Khlebnikova1, Anna Kirshina1, Natalia Zakharova1

  • 1Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia.

International Journal of Molecular Sciences
|December 17, 2024
PubMed
Summary

Messenger RNA (mRNA) vaccines show promise for preventing bacterial infections, offering a new strategy against evolving pathogens. This review explores current research and potential improvements for bacterial mRNA vaccines in animal models.

Keywords:
B. burgdorferiL. monocytogenesM. tuberculosisP. aeruginosaRNA vaccineS. pyogenesbacterial infection

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.2K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.8K

Related Experiment Videos

Last Updated: Jun 4, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.2K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.8K

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Bacterial infections pose a persistent threat due to antibiotic resistance and bacterial evolution.
  • Traditional antibiotics are becoming less effective, necessitating novel approaches for bacterial infection control.
  • Messenger RNA (mRNA) vaccine technology, successful against viral diseases, is being explored for bacterial infections.

Purpose of the Study:

  • To review the development and preclinical testing of mRNA vaccines against bacterial pathogens.
  • To analyze bacterial immune evasion mechanisms relevant to vaccine design.
  • To discuss strategies for enhancing the efficacy of bacterial mRNA vaccines.

Main Methods:

  • Review of existing literature on mRNA vaccine development for bacterial infections.
  • Analysis of bacterial structural features and immune evasion strategies.
  • Examination of in vivo experimental results from animal models using bacterial mRNA vaccines.

Main Results:

  • mRNA vaccines have been developed and tested in animal models against nine bacterial species.
  • The complexity of bacterial-host immune interactions presents challenges for vaccine efficacy.
  • Preclinical data indicate potential but also highlight areas for improvement in bacterial mRNA vaccine design.

Conclusions:

  • mRNA vaccines represent a promising avenue for combating bacterial infections.
  • Further research is needed to overcome challenges related to bacterial complexity and immune evasion.
  • Optimizing bacterial mRNA vaccine strategies is crucial for future clinical applications.